Shares of Glenmark Pharmaceuticals Ltd were trading in the green and 2% higher on 21 January after the company’s subsidiary, Glenmark Pharmaceuticals Inc., USA, announced the launching of Phytonadione Injectable Emulsion USP, 10 mg/mL single-dose ampules. 

The Phytonadione Injectable Emulsion USP, 10 mg/mL, are used to treat bleeding or blood clotting issues that are caused by vitamin K deficiency, conditions like obstructive jaundice and ulcerative colitis, or certain medications such as warfarin. 

Marc Kikuchi, president and business head, North America of Glenmark Pharmaceuticals, said, “We are excited to announce the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules, growing our portfolio of products within the institutional channel, while also strengthening our commitment to bring to market quality and affordable alternatives for patients.”

Glenmark’s Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules, is both bioequivalent and therapeutically equivalent to the reference drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL, produced by Hospira, Inc.

According to IQVIA sales data for the 12-month period ending November 2024, the market for Vitamin K1 Injectable Emulsion USP, 10 mg/mL, recorded annual sales of approximately $19.7 million.

Glenmark Pharmaceuticals is a globally focused, research-driven pharmaceutical company with expertise in Branded, generic, and OTC product segments. The company specialises in critical therapeutic areas, including respiratory, dermatology, and oncology.

Glenmark’s US portfolio includes 201 approved products and 51 Abbreviated New Drug Applications (ANDAs) currently pending FDA approval. In addition to its in-house development, Glenmark actively collaborates with external partners to enhance its pipeline and portfolio.

The company operates 11 advanced manufacturing facilities across four continents and has a presence in more than 80 countries worldwide.

At 11:42 am, the shares of Glenmark Pharma were trading 0.21% higher at Rs 1,506.75 on NSE. 

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!